Advance from pending sale of noncontrolling interest - related party
-
-
3,158,078
-
Accrued liabilities and other payables - related party
100,000
100,000
100,000
100,000
Derivative liability
29,442
34,156
100,423
125,553
Bridge loan payable, net
115,800
-
-
-
Note payable, net
1,142,027
-
-
-
Stock subscription liability
150,000
150,000
150,000
-
Operating lease obligation
83,508
6,000
71,691
69,573
Stock subscription liability
-
-
-
150,000
Convertible note payable, net
0
737,018
1,359,918
2,436,375
Advance from pending sale of noncontrolling interest - related party-Related Party
-
-
-
3,258,078
Current liabilities of discontinued operations
0
6,061,077
-
-
Accrued research and development fees
-
-
-
153,772
Advance from pending sale of subsidiary - related party
0
3,158,078
-
-
Total current liabilities
4,444,573
14,147,114
13,603,675
15,065,407
Operating lease obligation, noncurrent portion
76,837
-
17,799
35,022
Non-current liabilities of discontinued operations
0
23,515
-
-
Total non-current liabilities
76,837
23,515
17,799
35,022
Total liabilities
4,521,410
14,170,629
13,621,474
15,100,429
Preferred stock, value-Series BPreferred Stock
-
-
-
0
Preferred stock, value issued-Series DPreferred Stock
3,067,000
8,837,527
8,837,527
8,837,527
Preferred stock, value-Series APreferred Stock
-
-
-
0
Preferred stock, value issued-Series DConvertible Preferred Stock
8,837,527
-
-
-
Preferred stock, value
-
-
-
0
Preferred stock, value issued-Series EPreferred Stock
14,916,753
14,916,753
-
-
Common stock, 0.0001 par value 100,000,000 shares authorized 8,327,076 shares issued and 8,323,609 shares outstanding at march 31, 2026 4,857,476 shares issued and 4,854,009 shares outstanding at december 31, 2025
832
486
410
235
Additional paid-in capital
96,073,376
88,376,767
87,494,414
84,911,338
Less common stock held in treasury, at cost 3,467 shares at march 31, 2026 and december 31, 2025
522,500
522,500
522,500
-
Accumulated deficit
-110,413,796
-105,934,101
-103,868,102
-103,613,834
Less common stock held in treasury, at cost 3,467 shares at june 30, 2025 and december 31, 2024
-
-
-
522,500
Accumulated other comprehensive loss
-241,713
-241,402
-231,346
-231,617
Statutory reserve
6,578
6,578
6,578
6,578
Preferred stock, value issued-Series CPreferred Stock
0
3,790,000
3,790,000
3,500,000
Total avalon globocare corp. stockholders equity
11,724,057
9,230,108
-4,493,019
-7,112,273
Noncontrolling interest
0
-
-
0
Total equity
11,724,057
9,230,108
-4,493,019
-7,112,273
Total liabilities and equity
16,245,467
23,400,737
9,128,455
7,988,156
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.